Libeara Secures $14 Million in Strategic Round Led by GSR

Libeara, a Singapore-based firm specializing in digital asset infrastructure, announced on June 23, 2026, that it has successfully raised $14 million in a strategic funding round. The round was led by global market maker GSR, with participation from several notable investors, including Openspace Capital, Kyobo Life Insurance Group, AlloyX, Monk’s Hill Ventures, Kaia Investment Partners, and Simsan Ventures.

Company Overview

Founded by Aaron Gwak, who also serves as the CEO, Libeara is focused on providing infrastructure to facilitate the issuance and distribution of regulated digital assets. This latest funding highlights the increasing interest and investment in tokenization infrastructure, which aims to streamline how financial institutions and asset managers handle digital assets.

Strategic Use of Funds

The newly secured capital will be directed towards accelerating Libeara's global expansion. According to CEO Aaron Gwak, the company plans to enhance its infrastructure to make tokenized regulated assets accessible to a broader range of investors worldwide. "Bringing in these partners provides us a distinct edge in localizing and scaling our infrastructure across diverse markets," Gwak stated.

Investors and Market Position

The strategic round includes investors who bring diverse expertise in traditional financial markets and technology. Openspace Capital, for instance, is known for its investments in early-stage to growth technology companies across Web3 and enterprise software sectors. Their involvement, along with other investors, signals a strong belief in the potential of tokenized assets as a key component of future financial markets.

Conclusion

Libeara’s latest funding round marks a significant step in its journey to become a primary provider of tokenization infrastructure. With the backing of prominent investors and a clear focus on global expansion, the company is well-positioned to lead in the evolving landscape of digital asset management.